Skip to main content

Amphotericin B Lipid Complex Shortage

Last Updated: October 24, 2023
Status: Current

Products Affected - Description
    • Abelcet intravenous suspension for injection, Leadiant Biosciences, 100 mg, 20 mL vial, NDC 57665-0101-41
Reason for the Shortage
    • Leadiant Biosciences has Abelcet suspension for injection on back order due to a manufacturing issue.
    • Amphotericin B liposomal formulations are not affected by the shortage.
Available Products
    • There are no presentations available

Estimated Resupply Dates

    • Leadiant Biosciences has Abelcet 100 mg/20 mL vials on back order and the company cannot estimate a release date.


Updated October 24, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created August 5, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.